Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

News Daily News

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

September 20, 2021

Sapien 3 Valve Approved in Europe for Low-Risk Patients

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

FDA Expands TAVR Indication to Low-Risk Patients

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

News Daily News

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

January 02, 2019

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

June 05, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

March 22, 2017

News Daily News

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

October 27, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

August 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.